» Articles » PMID: 12737632

A Novel Function of Tissue-type Transglutaminase: Protein Disulphide Isomerase

Overview
Journal Biochem J
Specialty Biochemistry
Date 2003 May 10
PMID 12737632
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

We have found that tissue-type transglutaminase (tTG), also called TGc, TGase2 and Galpha(h), has the activity of protein disulphide isomerase (PDI). We have shown that tTG converts completely reduced/denatured inactive RNase A molecule to the native active enzyme. The PDI activity of tTG was strongly inhibited by bacitracin, which is a frequently used inhibitor of conventional PDI activity. It was substantially inhibited by the simultaneous presence of other potential substrate proteins such as completely reduced BSA, but not by native BSA. This activity was especially high in the presence of GSSG, but not GSH. The addition of GSH to the reaction mixture in the presence of GSSG at a fixed concentration up to at least 200-fold excess did not very substantially inhibit the PDI activity. It is possible that tTG can exert PDI activity in a fairly reducing environment like cytosol, where most of tTG is found. It is quite obvious from the following observations that PDI activity of tTG is catalysed by a domain different from that used for the transglutaminase reaction. Although the alkylation of Cys residues in tTG completely abolished the transglutaminase activity, as was expected, it did not affect the PDI activity at all. This PDI activity did not require the presence of Ca(2+). It was not inhibited by nucleotides including GTP at all, unlike the other activity of tTG.

Citing Articles

Distinct conformational states enable transglutaminase 2 to promote cancer cell survival versus cell death.

Aplin C, Zielinski K, Pabit S, Ogunribido D, Katt W, Pollack L Commun Biol. 2024; 7(1):982.

PMID: 39134806 PMC: 11319651. DOI: 10.1038/s42003-024-06672-x.


Effect of Ferulic Acid Loaded in Nanoparticle on Tissue Transglutaminase Expression Levels in Human Glioblastoma Cell Line.

DellAlbani P, Carbone C, Sposito G, Spatuzza M, Chiacchio M, Grasso R Int J Mol Sci. 2024; 25(15).

PMID: 39125966 PMC: 11312511. DOI: 10.3390/ijms25158397.


Transglutaminase 2-mediated histone monoaminylation and its role in cancer.

Li H, Wu J, Zhang N, Zheng Q Biosci Rep. 2024; 44(8).

PMID: 39115570 PMC: 11345673. DOI: 10.1042/BSR20240493.


Transglutaminase 2 Prevents Premature Senescence and Promotes Osteoblastic Differentiation of Mesenchymal Stem Cells through NRF2 Activation.

Lee S, Shin J, Kwon M, Lee K, Kim H, Lee J Stem Cells Int. 2023; 2023:8815888.

PMID: 37900967 PMC: 10611545. DOI: 10.1155/2023/8815888.


Biochemical and Functional Characterization of the Three Zebrafish Transglutaminases 2.

Lisetto M, Fattorini M, Lanza A, Gerdol M, Griffin M, Wang Z Int J Mol Sci. 2023; 24(15).

PMID: 37569416 PMC: 10419279. DOI: 10.3390/ijms241512041.


References
1.
WATTIAUX R . Subcellular localization of transglutaminase. Effect of collagen. Biochem J. 1988; 250(2):421-7. PMC: 1148873. DOI: 10.1042/bj2500421. View

2.
Achyuthan K, Greenberg C . Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity. J Biol Chem. 1987; 262(4):1901-6. View

3.
Gentile V, Saydak M, Chiocca E, Akande O, Birckbichler P, Lee K . Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases. J Biol Chem. 1991; 266(1):478-83. View

4.
Mizunaga T, Katakura Y, Miura T, Maruyama Y . Purification and characterization of yeast protein disulfide isomerase. J Biochem. 1990; 108(5):846-51. DOI: 10.1093/oxfordjournals.jbchem.a123291. View

5.
Greenberg C, Birckbichler P, Rice R . Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 1991; 5(15):3071-7. DOI: 10.1096/fasebj.5.15.1683845. View